Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Genetic identification of effectors downstream of Neu (ErbB-2) autophosphorylation sites in a Drosophila model

Abstract

The ErbB-2/Neu receptor tyrosine kinase plays a causal role in tumorigenesis in mammals. Neu's carboxyl terminus contains five phosphorylated tyrosines that mediate transformation through interaction with cytoplasmic SH2 or PTB containing adaptor proteins. We show that Drosophila adaptors signal from individual phosphotyrosine sites of rat Neu. Activated Neu expression in the midline glia suppressed apoptosis, similar to that seen with activated Drosophila EGF-R expression. Expression in eye and wing tissues generated graded phenotypes suitable for dosage-sensitive modifier genetics. Suppression of ErbB-2/Neu-induced phenotypes in tissues haplosufficient for genes encoding adaptor protein or second messengers suggests that pTyr 1227(YD) signals require Shc, and that pTyr 1253 (YE) signalling does not employ Ras, but does require Raf function. Signalling from pTyr (YB) was affected by a haplosufficiency in drk (Grb-2), and in genes thought to function downstream of Grb-2: dab, sos, csw (Shp-2), and dos (Gab-1). These data demonstrate the power of Drosophila genetics to unmask the molecules that signal from oncogenic ErbB-2/Neu.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Baker NE and Rubin GM . (1989). Nature, 340, 150–153.

  • Bargmann CI and Weinberg RA . (1988). EMBO J., 7, 2043–2052.

  • Baumann P and Skaer H . (1993). Dev. Suppl., 65–75.

  • Bhandari P and Shashidhara LS . (2001). Oncogene, 20, 6871–6880.

  • Brand AH, Manoukian AS and Perrimon N . (1994). Methods Cell Biol., 44, 635–654.

  • Buday L and Downward J . (1993). Cell, 73, 611–620.

  • Cleghon V, Feldmann P, Ghiglione C, Copeland TD, Perrimon N, Hughes DA and Morrison DK . (1998). Mol. Cell, 2, 719–727.

  • Cunnick J, Mei L, Doupnik C and Wu J . (2001). J. Biol. Chem., 276, 24380–24387.

  • Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z, Moran MF, Oshima RG, Cardiff RD and Muller WJ . (2001). Mol. Cell Biol., 21, 1540–1551.

  • Dankort DL and Muller WJ . (2000). Oncogene, 19, 1038–1044.

  • Dankort DL, Wang Z, Blackmore V, Moran MF and Muller WJ . (1997). Mol. Cell Biol., 17, 5410–5425.

  • Dong R and Jacobs JR . (1997). Dev. Biol., 190, 165–177.

  • Dougall WC, Qian X, Miller MJ and Greene MI . (1996). DNA Cell Biol., 15, 31–40.

  • Firth L, Manchester J, Lorenzen JA, Baron M and Perkins LA . (2000). Genetics, 156, 733–748.

  • Gayko U, Cleghon V, Copeland T, Morrison DK and Perrimon N . (1999). Proc. Natl. Acad. Sci. USA, 96, 523–528.

  • Gotoh N, Tojo A and Shibuya M . (1996). EMBO J., 15, 6197–6204.

  • Gu H, Maeda H, Moon JJ, Lord JD, Yoakim M, Nelson BH and Neel BG . (2000). Mol. Cell Biol., 20, 7109–7120.

  • Gustafson K and Boulianne GL . (1996). Genome, 39, 174–182.

  • Hay BA, Maile R and Rubin GM . (1997). Proc. Natl. Acad. Sci. USA, 94, 5195–5200.

  • Herbst R, Zhang X, Qin J and Simon MA . (1999). EMBO J., 18, 6950–6961.

  • Hynes NE and Stern DF . (1994). Biochim. Biophys. Acta, 1198, 165–184.

  • Jacobs JR . (2000). Prog. Neurobiol., 62, 475–508.

  • Johnson Hamlet MR and Perkins LA . (2001). Genetics, 159, 1073–1087.

  • Kavanaugh WM, Turck CW and Williams LT . (1995). Science, 268, 1177–1179.

  • Klambt C, Jacobs JR and Goodman CS . (1991). Cell, 64, 801–815.

  • Kurada P and White K . (1998). Cell, 95, 319–329.

  • Lai KM, Olivier JP, Gish GD, Henkemeyer M, McGlade J and Pawson T . (1995). Mol. Cell Biol., 15, 4810–4818.

  • Lanoue BR, Gordon MD, Battye R and Jacobs JR . (2000). Genome, 43, 564–573.

  • Lanoue BR and Jacobs JR . (1999). Dev. Genet., 25, 321–330.

  • Le N and Simon MA . (1998). Mol. Cell Biol., 18, 4844–4854.

  • Lee T, Feig L and Montell DJ . (1996). Development, 122, 409–418.

  • Lesa GM and Sternberg PW . (1997). Mol. Biol. Cell, 8, 779–793.

  • Lesokhin AM, Yu SY, Katz J and Baker NE . (1999). Dev. Biol., 205, 129–144.

  • Lock P, Casagranda F and Dunn AR . (1999). J. Biol. Chem., 274, 22775–22784.

  • Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D and Schlessinger J . (1992). Cell, 70, 431–442.

  • Lu X, Melnick MB, Hsu JC and Perrimon N . (1994). EMBO J., 13, 2592–2599.

  • Ludlow C, Choy R and Blochlinger K . (1996). Dev. Biol., 178, 149–159.

  • Maixner A, Hecker TP, Phan QN and Wassarman DA . (1998). Dev. Genet., 23, 347–361.

  • Margolis B, Borg JP, Straight S and Meyer D . (1999). Kidney Int., 56, 1230–1237.

  • Obermeier A, Tinhofer I, Grunicke HH and Ullrich A . (1996). EMBO J., 15, 73–82.

  • Olivier JP, Raabe T, Henkemeyer M, Dickson B, Mbamalu G, Margolis B, Schlessinger J, Hafen E and Pawson T . (1993). Cell, 73, 179–191.

  • Patel NH . (1994). Methods Cell Biol., 44, 445–487.

  • Pawson T . (1994). Adv. Cancer Res., 64, 87–110.

  • Pawson T and Nash P . (2000). Genes Dev., 14, 1027–1047.

  • Pawson T, Olivier P, Rozakis-Adcock M, McGlade J and Henkemeyer M . (1993). Philos. Trans. R. Soc. London B Biol. Sci., 340, 279–285.

  • Peles E, Levy RB, Or E, Ullrich A and Yarden Y . (1991). EMBO J., 10, 2077–2086.

  • Phelps CB and Brand AH . (1998). Methods, 14, 367–379.

  • Raz E and Shilo BZ . (1993). Genes Dev., 7, 1937–1948.

  • Ricci A, Lanfrancone L, Chiari R, Belardo G, Pertica C, Natali PG, Pelicci PG and Segatto O . (1995). Oncogene, 11, 1519–1529.

  • Rogge RD, Karlovich CA and Banerjee U . (1991). Cell, 64, 39–48.

  • Ross JS and Fletcher JA . (1999). Semin. Cancer Biol., 9, 125–138.

  • Rozakis-Adcock M, Fernley R, Wade J, Pawson T and Bowtell D . (1993). Nature, 363, 83–85.

  • Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T and Pelicci PG . (1994). Oncogene, 9, 2827–2836.

  • Schlessinger J . (2000). Cell, 103, 211–225.

  • Shilo BZ and Raz E . (1991). Trends Genet., 7, 388–392.

  • Simon JA and Schreiber SL . (1995). Chem. Biol., 2, 53–60.

  • Simon MA, Bowtell DD, Dodson GS, Laverty TR and Rubin GM . (1991). Cell, 67, 701–716.

  • Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Farjardo JE, Chou MM, Hanafusa H, Schaffhausen B and Cantley LC . (1993). Cell, 72, 767–778.

  • Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Reh R, Baltimore D, Ratnofsky S, Feldman RA and Cantley LC . (1994). Mol. Cell Biol., 14, 2777–2785.

  • Stern MJ, Marengere LE, Daly RJ, Lowenstein EJ, Kokel M, Batzer A, Olivier P, Pawson T and Schlessinger J . (1993). Mol. Biol. Cell, 4, 1175–1188.

  • Stewart BA, Mohtashami M, Zhou L, Trimble WS and Boulianne GL . (2001). Dev. Biol., 234, 13–23.

  • Sturtevant MA and Bier E . (1995). Development, 121, 785–801.

  • Sturtevant MA, Roark M and Bier E . (1993). Genes. Dev., 7, 961–973.

  • Therrien M, Chang HC, Solomon NM, Karim FD, Wassarman DA and Rubin GM . (1995). Cell, 83, 879–888.

  • van der Geer P and Pawson T . (1995). Trends Biochem. Sci., 20, 277–280.

  • van der Geer P, Wiley S, Gish GD, Lai VK, Stephens R, White MF, Kaplan D and Pawson T . (1996). Proc. Natl. Acad. Sci. USA, 93, 963–968.

  • Weiner DB, Liu J, Cohen JA, Williams WV and Greene MI . (1989). Nature, 339, 230–231.

  • Whitfield CW, Benard C, Barnes T, Hekimi S and Kim SK . (1999). Mol. Biol. Cell, 10, 2087–2100.

  • Xu XX, Yi T, Tang B and Lambeth JD . (1998). Oncogene, 16, 1561–1569.

Download references

Acknowledgements

We are grateful to M Simon, L Perkins, D Montell, P Martin, S Luschnig, M Gates, G Boulianne, and N Baker for providing mutant stocks. This work was supported by the National Cancer Institute of Canada with funds from the Canadian Cancer Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Roger Jacobs.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Settle, M., Gordon, M., Nadella, M. et al. Genetic identification of effectors downstream of Neu (ErbB-2) autophosphorylation sites in a Drosophila model. Oncogene 22, 1916–1926 (2003). https://doi.org/10.1038/sj.onc.1206240

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206240

Keywords

This article is cited by

Search

Quick links